リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Systemic adverse events after screening of retinopathy of prematurity with mydriatic.」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。
リケラボ

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Systemic adverse events after screening of retinopathy of prematurity with mydriatic.

OBATA Shumpei 90814848 0000-0001-6120-2392 IMAMURA Taku KAKINOKI Masashi 80531516 YANAGI Takahide 70418755 MARUO Yoshihiro 80314160 OHJI Masahito 90252650 滋賀医科大学

2021.09.09

概要

Purpose:
To evaluate systemic adverse events after screening for retinopathy of prematurity (ROP) performed with mydriatic.
Methods:
This was a retrospective case series study. Medical records of consecutive patients who underwent screening for ROP with 0.5% phenylephrine and 0.5% tropicamide eyedrops were retrospectively reviewed. The score of abdominal distention (0-5), volume of milk sucked and volume of stool, along with systemic details (pulse and respiration rates, blood pressure and number of periods of apnea) were collected at 1 week and 1 day before ROP examination, and at 1 day after examination. Results were compared between the days before and after examination. Correlation between body weight at the time of examination and the score of abdominal distention was examined. The numbers of infants with abdominal and/or systemic adverse events were compared between pre- and post-examination periods.
Results:
Eighty-six infants met the inclusion criteria. The score of abdominal distention increased from 2.0 at 1 day before examination to 2.3 at 1 day after examination (p = 0.005), and the number of infants who had worsened abdominal distension increased after examination (p = 0.01). Infants with lower body weight had a higher score of abdominal distention (p < 0.0001, r = -0.57). The number of infants with reduced milk consumption increased after examination (p = 0.0001), as did the number of infants with decreased pulse rate (p = 0.0008).
Conclusions:
Screening for ROP with mydriatic may have adverse effects on systemic conditions. Infants should be carefully monitored after ROP screening with mydriatic.

論文の公開元へ

この論文で使われている画像

関連論文

関連論文をもっと見る

参考文献

1.

Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk

and implications for control. Early Hum Dev. 2008; 84(2):77–82. Epub 2008/02/01. https://doi.org/10.

1016/j.earlhumdev.2007.11.009 PMID: 18234457.

2.

Rengstorff RH, Doughty CB. Mydriatic and cycloplegic drugs: a review of ocular and systemic complications. Am J Optom Physiol Opt. 1982; 59(2):162–77. Epub 1982/02/01. PMID: 7039329.

3.

Kremer LJ, Reith DM, Medlicott N, Broadbent R. Systematic review of mydriatics used for screening of

retinopathy in premature infants. BMJ Paediatr Open. 2019; 3(1):e000448. https://doi.org/10.1136/

bmjpo-2019-000448 PMID: 31206081.

4.

Mitchell A, Hall RW, Erickson SW, Yates C, Lowery S, Hendrickson H. Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams. Curr Eye Res. 2016; 41

(12):1601–7. https://doi.org/10.3109/02713683.2015.1136419 PMID: 27159349.

5.

Bonthala S, Sparks JW, Musgrove KH, Berseth CL. Mydriatics slow gastric emptying in preterm infants.

J Pediatr. 2000; 137(3):327–30. Epub 2000/09/02. https://doi.org/10.1067/mpd.2000.107842 PMID:

10969255.

6.

Mitchell AJ, Green A, Jeffs DA, Roberson PK. Physiologic effects of retinopathy of prematurity screening examinations. Adv Neonatal Care. 2011; 11(4):291–7. Epub 2011/11/30. https://doi.org/10.1097/

ANC.0b013e318225a332 PMID: 22123352.

7.

Jiang JB, Zhang ZW, Zhang JW, Wang YL, Nie C, Luo XQ. Systemic changes and adverse effects

induced by retinopathy of prematurity screening. Int J Ophthalmol. 2016; 9(8):1148–55. https://doi.org/

10.18240/ijo.2016.08.11 PMID: 27588270.

8.

Fierson WM, American Academy of Pediatrics Section on O, American Academy of O, American Association for Pediatric O, Strabismus, American Association of Certified O. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013; 131(1):189–95. https://doi.org/10.1542/

peds.2012-2996 PMID: 23277315.

9.

Degirmencioglu H, Oncel MY, Calisici E, Say B, Uras N, Dilmen U. Transient ileus associated with the

use of mydriatics after screening for retinopathy of prematurity in a very low birth weight infant. J Pediatr

Ophthalmol Strabismus. 2014; 51 Online:e44–7. Epub 2014/07/09. https://doi.org/10.3928/0191391320140701-02 PMID: 25003832.

10.

Sarici SU, Yurdakok M, Unal S. Acute gastric dilatation complicating the use of mydriatics in a preterm

newborn. Pediatr Radiol. 2001; 31(8):581–3. Epub 2001/09/12. https://doi.org/10.1007/

s002470100498 PMID: 11550771.

11.

Gronlund JU, Antila KJ, Siimes AS, Metsala T, Oja R, Tuominen J, et al. Beta-adrenergic control and

inter-relationships between heart rate and blood pressure in neonatal lambs. Med Biol Eng Comput.

1989; 27(2):163–70. Epub 1989/03/01. https://doi.org/10.1007/BF02446226 PMID: 2574762.

12.

Isenberg S, Everett S, Parelhoff E. A comparison of mydriatic eyedrops in low-weight infants. Ophthalmology. 1984; 91(3):278–9. https://doi.org/10.1016/s0161-6420(84)34303-2 PMID: 6546977.

13.

Lees BJ, Cabal LA. Increased blood pressure following pupillary dilation with 2.5% phenylephrine

hydrochloride in preterm infants. Pediatrics. 1981; 68(2):231–4. PMID: 7267230.

14.

Laws DE, Morton C, Weindling M, Clark D. Systemic effects of screening for retinopathy of prematurity.

Br J Ophthalmol. 1996; 80(5):425–8. Epub 1996/05/01. https://doi.org/10.1136/bjo.80.5.425 PMID:

8695564.

15.

Phamonvaechavan P, Chutasmit K, Damrongrak P, Koukiatkul S, Wongkiatkajorn T, Ngerncham S.

Comparison of the effectiveness of mydriasis by two instillation methods of combined 0.75% tropicamide and 2.5% phenylephrine eye drop in preterm infants. J Med Assoc Thai. 2012; 95 Suppl 4:S1–7.

Epub 2012/06/16. PMID: 22696845.

PLOS ONE | https://doi.org/10.1371/journal.pone.0256878 September 9, 2021

9 / 10

PLOS ONE

Adverse events after ROP screening

16.

Khoo BK, Koh A, Cheong P, Ho NK. Combination cyclopentolate and phenylephrine for mydriasis in

premature infants with heavily pigmented irides. J Pediatr Ophthalmol Strabismus. 2000; 37(1):15–20.

PMID: 10714690.

17.

Rosales T, Isenberg S, Leake R, Everett S. Systemic effects of mydriatics in low weight infants. J

Pediatr Ophthalmol Strabismus. 1981; 18(6):42–4. Epub 1981/11/01. PMID: 7334446.

18.

Rush R, Rush S, Nicolau J, Chapman K, Naqvi M. Systemic manifestations in response to mydriasis

and physical examination during screening for retinopathy of prematurity. Retina. 2004; 24(2):242–5.

https://doi.org/10.1097/00006982-200404000-00009 PMID: 15097885.

19.

Bolt B, Benz B, Koerner F, Bossi E. A Mydriatic Eye-Drop Combination Without Systemic Effects for

Premature Infants: A Prospective Double-Blind Study J Pediatr Ophthalmol Strabismus 1992; 29

(3):157–62. PMID: 1432499

PLOS ONE | https://doi.org/10.1371/journal.pone.0256878 September 9, 2021

10 / 10

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文
を
一発検索！

この論文の関連論文を見る